Nyxoah (NASDAQ:NYXH – Get Free Report) and Alternate Health (OTCMKTS:AHGIF – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
Analyst Ratings
This is a breakdown of recent recommendations for Nyxoah and Alternate Health, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nyxoah | 0 | 0 | 4 | 0 | 3.00 |
Alternate Health | 0 | 0 | 0 | 0 | 0.00 |
Nyxoah presently has a consensus target price of $14.50, suggesting a potential upside of 76.40%. Given Nyxoah’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Nyxoah is more favorable than Alternate Health.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Nyxoah | -1,571.39% | -63.37% | -46.67% |
Alternate Health | N/A | N/A | N/A |
Earnings & Valuation
This table compares Nyxoah and Alternate Health”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nyxoah | $4.89 million | 57.25 | -$64.10 million | ($2.13) | -3.86 |
Alternate Health | N/A | N/A | N/A | N/A | N/A |
Alternate Health has lower revenue, but higher earnings than Nyxoah.
Summary
Nyxoah beats Alternate Health on 4 of the 7 factors compared between the two stocks.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
About Alternate Health
Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.